Health Talks — Dueling Epidemics: The Opioid Crisis in the Era of COVID-19

Health Talks — Dueling Epidemics: The Opioid Crisis in the Era of COVID-19

Publication date: Sep 04, 2025

Um, we’re talking about FDA approved medications to treat opioid use disorder and alcohol use uh disorder um in combination hopefully with uh behavioral therapies, psychosocial uh treatments. So in conclusion, um as Dr. Goyer pointed out, we see that even uh short-term opioid prescriptions come with the risk of developing uh an opioid use disorder. Um, I I can say with with um medications for alcohol use disorder, we know that they’re widely underutilized just like medications for um for opioid use disorder. And uh detox is the type type of treatment uh for opio that people with opioid use disorder uh attend. Um, so methadone, which probably has some name recognition for everyone, has been FDA approved for uh opioid use disorder treatment uh since the early 70s. And then lastly, uh Nrexone, which actually treats alcohol use disorder and opioid use disorder, the only medication that treats uh multiple substance use disorders. Um, so this is a 25 yearear-old woman and uh when I talked to her, she was in treatment for opioid use disorder and she explained uh her experiences.

Concepts Keywords
Cocaine Arizona
Dueling Disorder
Mexico Dr
Outpatient Drug
Drugs
Important
Medication
Medications
Opioid
Opioids
Overdose
Patient
Prescribing
Risk
Treatment

Semantics

Type Source Name
disease MESH COVID-19
disease MESH death
disease MESH opioid use disorders
disease MESH access to health care
disease MESH relapse
disease MESH chronic disease
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Tropicamide
disease MESH substance use
disease IDO quality
disease MESH data sources
drug DRUGBANK Diamorphine
drug DRUGBANK Fentanyl
disease IDO country
disease IDO process
drug DRUGBANK Oxycodone
drug DRUGBANK Cocaine
drug DRUGBANK Metamfetamine
disease MESH emergency
drug DRUGBANK Opium
pathway REACTOME Translation
disease MESH causes
drug DRUGBANK Morphine
disease MESH malignancy
pathway REACTOME Release
disease IDO history
disease MESH depression
disease MESH anxiety
disease MESH functional status
disease MESH pain disorder
disease MESH lifestyle
drug DRUGBANK Aspartame
drug DRUGBANK Buprenorphine
drug DRUGBANK Ilex paraguariensis leaf
disease MESH chronic pain
drug DRUGBANK Ethanol
drug DRUGBANK Methadone
disease MESH withdrawal symptoms
disease MESH alcohol use disorder
drug DRUGBANK Aminosalicylic Acid
disease IDO role
drug DRUGBANK Huperzine B
drug DRUGBANK Nicotine
drug DRUGBANK Medical Cannabis
disease MESH marijuana use

Original Article

(Visited 8 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *